Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05726903

Counseling Among Gender Diverse Adolescents Who Use Depot Medroxyprogesterone

Conditions: Gender Dysphoria, Adolescent

Sex: Female
Ages: 15 Years – 21 Years
Healthy volunteers: 1
Phase: PHASE4
Enrollment: 40
Sponsor: University of Colorado, Denver

Location: United States

Summary

Recommendations regarding contraceptive counseling and reproductive health differ amongst transgender and gender diverse (TGD) youth compared to cis-gender youth. Limited existing literature demonstrates the need for contraceptive counseling that moves beyond cis- and heteronormative assumptions that start with pregnancy prevention and address concerns at the intersection of gender identity.The Investigator's qualitative study will focus on creating best practices regarding equitable contraceptive counseling for TGD youth. The Investigator will recruit transgender youth who are assigned female at birth, and currently or interested in using depo medroxyprogesterone (DMPA). Through focus groups and semi-structured interviews, the investigator hopes to guide providers in creating best practices and more equitable contraceptive counseling for TGD youth and measure satisfaction of DMPA in TGD youth.

Eligibility Criteria

Inclusion Criteria:between the ages of 15-21,currently receiving care at one of the clinic sites, assigned female at birth, identify as transgender or gender diverse , and are currently using or are interested in using DMPA.Exclusion Criteria:Any contraindications to DMPA (based on any category 3 or 4 recommendations from the CDC MEC guidelines)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05726903). StuddyBuddy aggregates publicly available trial information.